FIELD: medicine.
SUBSTANCE: pharmaceutical composition containing fibrin glue and a recovered homogenous cell population produced from human umbilical cord tissues in an amount effective to treat a disease; the umbilical cord tissue is substantially blood-free, is applied locally. The above recovered homogenous cell population is self-renewing and propagating in a culture, has a differentiation potential and does not express CD117 and/or telomerase.
EFFECT: using the given inventions enables increasing reperfusion in a patient suffering a peripheral vascular disease by the local use of umbilical cord tissue cells.
34 cl, 7 ex, 13 dwg, 7 tbl
